Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
81K
-
Shares change
-
-57.6K
-
Total reported value, excl. options
-
$178K
-
Value change
-
-$137K
-
Number of buys
-
3
-
Number of sells
-
-4
-
Price
-
$2.20
Significant Holders of Arcadia Biosciences, Inc. - COM (RKDA) as of Q1 2024
15 filings reported holding RKDA - Arcadia Biosciences, Inc. - COM as of Q1 2024.
Arcadia Biosciences, Inc. - COM (RKDA) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 81K shares
.
Largest 10 shareholders include SABBY MANAGEMENT, LLC (40.3K shares), VANGUARD GROUP INC (14K shares), STATE STREET CORP (12.1K shares), RENAISSANCE TECHNOLOGIES LLC (10.5K shares), Tower Research Capital LLC (TRC) (3.77K shares), MORGAN STANLEY (207 shares), GROUP ONE TRADING, L.P. (18 shares), WELLS FARGO & COMPANY/MN (9 shares), US BANCORP \DE\ (5 shares), and OLIVER LAGORE VANVALIN INVESTMENT GROUP (4 shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.